Association of fetal outcomes with medications taken before or during pregnancy, in liver and cardiothoracic transplant recipients (n = 77)1.

Data are shown as n (%), with percentages referring to complete data only, except for the last column which gives odds ratios with 95% confidence intervals in parentheses.1Denominator refers to all pregnancies, including one multiple pregnancy, but with cluster analysis for 70 women as six women had repeated pregnancies.2Poor fetal outcome was defined as any pregnancy resulting in a stillbirth, miscarriage, very low birthweight (th centile, best-case scenario), congenital anomaly, neonatal unit admission and very preterm birth (3Refers to medications taken before and/or during pregnancy.4Refers to medications taken before pregnancy.ACE = Angiotensin-converting enzyme inhibitor; ARB = Angiotensin II receptor antagonist.

数据以例数（百分比）的形式呈现，其中百分比仅针对完整有效数据计算，最后一列除外；该列以括号内形式给出比值比（Odds Ratio, OR）及95%置信区间（Confidence Interval, CI）。
1. 分母为所有妊娠（含1例多胎妊娠），但因6名女性存在重复妊娠史，故对70名女性开展聚类分析。
2. 不良胎儿结局定义为任何妊娠出现死胎、流产、极低出生体重（百分位数，最优场景）、先天性畸形、新生儿科收治以及极早早产。
3. 指妊娠前及/或妊娠期间服用的药物。
4. 指妊娠前服用的药物。
术语说明：ACE = 血管紧张素转换酶抑制剂（Angiotensin-converting enzyme inhibitor）；ARB = 血管紧张素Ⅱ受体拮抗剂（Angiotensin II receptor antagonist）。